3rd Party Biotechnology Industry News

Intellia Therapeutics has temporarily paused dosing and screening in a [...]

Zenas Biopharma’s lead autoimmune drug has been tied to a [...]

Almost a year after buying Kate Therapeutics, Novartis has scooped [...]

Just as Adverum’s cash reserves were running dry, Eli Lilly [...]

Biogen plans to beef up its early-stage immunology pipeline by [...]

Sanofi has dropped its respiratory syncytial virus vaccine for toddlers [...]

Ophthalmology biotech veteran Gregory Kunst has found his next venture [...]

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 [...]

Regeneron has given up on a CAR-T candidate acquired from [...]

Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker [...]